Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Ovarian Neoplasms × Mercaptopurine × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1 Breast 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 57 Leukemia 40 Lymphoma 11 Burkitt Lymphoma 6 Neoplasm, Residual 4 Leukemia, Promyelocytic, Acute 4 Leukemia, Biphenotypic, Acute 4 Lymphoma, Large B-Cell, Diffuse 2 Leukemia, Myeloid, Acute 2 Dendritic Cell Sarcoma, Interdigitating 2 Thrombocytopenia 1 Rare Diseases 1 Psoriasis 1 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1 Philadelphia Chromosome 1 Ovarian Neoplasms 1 Oligodendroglioma 1 Neutropenia 1 Neoplasms 1 Neoplasm Metastasis 1 Mucositis 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Mantle-Cell 1 Lymphoma, Large-Cell, Immunoblastic 1 Lymphoma, Large-Cell, Anaplastic 1 Lymphoma, B-Cell, Marginal Zone 1 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Leukemia, Erythroblastic, Acute 1 Inflammatory Bowel Diseases 1

Interventions

Carboplatin 160 Paclitaxel 153 Bevacizumab 65 Topotecan 49 liposomal doxorubicin 47 Gemcitabine 47 Cisplatin 40 Cyclophosphamide 35 Docetaxel 34 Filgrastim 27 pembrolizumab 26 Doxorubicin 26 olaparib 25 niraparib 19 Drug Therapy 19 Taxes 18 Peripheral Blood Stem Cell Transplantation 18 Etoposide 15 Nivolumab 14 veliparib 13 sargramostim 12 Surveys and Questionnaires 12 Trabectedin 11 Immunoglobulin G 11 Ifosfamide 11 Disulfides 11 Albumin-Bound Paclitaxel 11 pazopanib 10 durvalumab 10 atezolizumab 10

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01432145 2019-07-09

6MP

University of Oxford

Phase 2 Completed

74 enrolled 13 charts

BreastGynecologic

Breast Neoplasms, Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡